Risk-factor analysis and predictive-model development of acute kidney injury in inpatients administered cefoperazone-sulbactam sodium and mezlocillin-sulbactam sodium: a single-center retrospective study

• Główni autorzy: Ruiqiu Zhang (Autor), Liming Gao (Autor), Ping Chen (Autor), Weiguo Liu (Autor), Xin Huang (Autor), Xiao Li (Autor)
• Format: Książka
• Wydane: Frontiers Media S.A., 2023-06-01T00:00:00Z.
• Hasła przedmiotowe: article
• Dostęp online: Connect to this object online.

Objective: Acute kidney injury (AKI) is a common adverse reaction observed with the clinical use of cefoperazone-sulbactam sodium and mezlocillin-sulbactam sodium. Based upon real-world data, we will herein determine the risk factors associated with AKI in inpatients after receipt of these antimicro...